Diabetic Sarcopenia Nutrition Market

Market Size (2026)
USD 263.4 Mn
Forecast (2036)
USD 658.7 Mn
CAGR (2026 to 2036)
9.6%

How big is Diabetic Sarcopenia Nutrition Market in 2026?

Demand for diabetic sarcopenia nutrition is projected to expand at 9.6% CAGR between 2026 and 2036. Industry value grows from USD 240.3 million in 2025 to USD 263.4 million in 2026 and is projected to reach USD 658.7 million by 2036.

Diabetic sarcopenia nutrition market is estimated to grow at 9.6% CAGR through 2036. Valuation grew from USD 240.3 million in 2025 to USD 263.4 million in 2026 and is projected to reach USD 658.7 million by 2036. Increasing number of older adults with diabetes are facing poor intake and reduction of muscle, due to which the requirement for specialized nutrition per diagnosed patient is increasing. In April 2025, the International Diabetes Federation reported that 589 million adults globally live with diabetes, accelerating clinical demand for targeted muscle-preservation support. This is expected to identify nutrition requirement before severe weakness starts. Increasing preference for protein with controlled carbohydrate delivery is supporting low-GI high-protein formulas. Also, wider use across hospitals, pharmacies and homecare is boosting clinical nutrition reach. Compact premium-grade servings are expected to gain higher preference where poor appetite restricts the intake of larger drinks.

Diabetic sarcopenia nutrition demand is not developing in the same manner across every country, as Japan is projected at 10.2% CAGR, while South Korea is forecast at 9.9% through 2036. In November 2025, the World Health Organization reported that over 220 million adults across the Western Pacific region are living with diabetes, expanding the older cohort vulnerable to secondary sarcopenia. The USA is projected at 9.2% owing to hospital, pharmacy and homecare access. The UK at 8.9% and Germany at 8.3% are expected to grow with structured medical food use. However, product buying will differ according to reimbursement, serving preference, renal condition, swallowing requirement and professional recommendation. Hence, documented nutrition need, product suitability and qualification for continued use will remain the final commercial filter.

Diabetic Sarcopenia Nutrition Market Value Analysis chart showing growth from USD 263.4 million in 2026 to USD 658.7 million by 2036 at a CAGR of 9.6%
Diabetic Sarcopenia Nutrition Market Value Analysis

Key Takeaways of Diabetic Sarcopenia Nutrition Market

  • Demand rises when older-adult diabetes care identifies muscle loss, poor intake, or frailty beside glycemic control.
  • Based on formulation, low-GI high-protein ONS is projected to account for 41.6% in 2026 owing to dual nutrition needs.
  • By product form, RTD is estimated to hold 46.3% in 2026 due to measured servings and limited preparation.
  • In 2026, adults aged 60-69 years are expected to lead age group demand with 48.9% share because self-directed use remains practical.
  • Japan is projected at 10.2% CAGR, while South Korea is forecast at 9.9% as both countries address older-adult diabetes and muscle loss.
  • Notable companies in the diabetic sarcopenia nutrition market include Abbott, Nestlé Health Science, Danone Nutricia, Meiji, Ajinomoto, Fresenius Kabi, Morinaga Milk Industry, and Medtrition.

Analyst Perspective

“Frailty screening will move nutrition demand before severe muscle decline starts. Compact formulas having better tolerance will gain regular homecare adoption.”

- Anurag Sharma, Principal Consultant, Future Market Insights.

How is the Diabetic Sarcopenia Nutrition Market segmented?

Diabetic sarcopenia nutrition market is segmented by five primary commercial axes and region: formulation, product form, age group, end user, sales channel, and region. Low-GI high-protein ONS, RTD, and adults aged 60-69 years are projected at 41.6%, 46.3%, and 48.9% in 2026.

By formulation: low-GI high-protein ONS; leucine or HMB-enriched diabetic blends; whey-based diabetic protein powders; others.

By product form: RTD; powders; puddings and semi-solids; others.

By age group: 60-69 years; 70-79 years; 80+ years.

By end user: homecare; long-term care; hospitals; others.

By sales channel: hospital pharmacy; retail pharmacy; online; institutional tender; others.

By region: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.

Why does low-GI high-protein ONS lead formulation demand?

Diabetic Sarcopenia Nutrition Market Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
Diabetic Sarcopenia Nutrition Market Analysis by Diabetic Sarcopenia Nutrition Market by Formulation

Based on formulation, low-GI high-protein ONS is projected to account for 41.6% in 2026, driven by dual clinical requirements.

Increasing requirement for protein nutrition without higher carbohydrate load is driving the adoption of specialized formulas developed alongside mainstream sports nutrition science. Older adults with diabetes and muscle loss cannot consume every high-calorie nutrition drink, as higher sugar intake can disturb the existing glucose-management routine. Low-GI high-protein ONS offers protein and controlled carbohydrate delivery in one product, which makes the formula suitable for both requirements. In November 2025, Abbott launched reformulated Ensure Diabetes Care with low-GI carbohydrates, high protein and high fiber, and connected the formula with preservation of lean muscle during weight loss. This shows that diabetes nutrition is moving from calorie replacement towards muscle preservation as well. Increasing screening for poor intake and loss of strength is expected to support the segment demand. However, renal condition, appetite and tolerance can possibly restrict continued use.

  • Low-GI high-protein ONS is projected to account for 41.6% in 2026 owing to dual protein and glucose requirements.
  • Increasing muscle-preservation requirement is expected to move the segment beyond general calorie replacement.

What supports RTD as a preferred product form?

By product form, RTD is estimated to hold 46.3% in 2026, owing to measured intake and limited preparation.

Increasing need for measured nutrition with minimum preparation is supporting the demand for RTD products. RTD products remove mixing and provide the same quantity in every serving, due to which older adults and caregivers do not need to measure powder, water and concentration each time. Small serving volume is useful for people having poor appetite and unable to complete a large diabetic food serving. Also, the same RTD product started in hospital can be continued at home without changing the preparation routine. These advantages are expected to keep RTD as the preferred product form. Higher price, storage and repeated flavor use are factors that can hamper longer daily consumption.

  • RTD is estimated to hold 46.3% of product-form demand in 2026. Measured servings, compact volume and no mixing requirement are supporting the segment.
  • Compact volume is also expected to support use where poor appetite restricts larger drinks.

How do adults aged 60-69 years sustain age-group demand?

In 2026, adults aged 60-69 years are expected to lead age group demand with 48.9% share, supported by self-management.

Adults aged 60-69 years generally manage medicines, shopping and meal routines without full-time care, due to which prediabetes nutrition products and specialized drinks can be included in the existing diabetes routine with lower caregiver support. In January 2025, the Korean Diabetes Association reported that diabetes prevalence reached 29.3% in adults aged 65 and older, while 78.8% maintained independent treatment awareness. Increasing screening for weakness, poor intake and reduction in physical function can identify nutrition requirement before dependence on family or institutional care starts. Also, this age group can use portable RTD servings and basic powder instructions without major change in everyday routine. These factors are anticipated to support higher demand from adults aged 60-69 years. However, age alone will not drive the adoption of specialized nutrition, as documented muscle loss, frailty or inadequate intake will remain the major requirement for product selection.

  • Adults aged 60-69 years are expected to lead with 48.9% share in 2026 owing to practical self-use.
  • Screening can identify declining strength before high supervision and texture changes are required.

Why does homecare hold the main end-user position?

Homecare is projected to hold 47.2% of end-user demand in 2026, enabled by repeat use after clinical initiation.

Nutrition use continues for weeks or months after the first hospital or clinic assessment, which makes homecare the main place for regular use. Increasing care of older adults at home and wider online purchase is supporting demand for older adults health supplements outside acute hospital settings. In July 2025, Danone completed its majority acquisition of Kate Farms and stated that the combined platform would serve hospitals, homes, online channels and retail. Such channel spread can move the same product from clinical recommendation to repeat household purchase. In addition, availability of the same pack, flavor and serving size can reduce breaks after discharge. Household cost, caregiver understanding and daily tolerance are some of the factors that can possibly affect product continuation for the complete recommended period.

  • Homecare is projected to hold 47.2% in 2026 owing to repeat use after clinical initiation.
  • Availability of the same product after discharge is expected to reduce breaks in routine use.

What keeps hospital pharmacy central to sales channels?

Hospital pharmacy is forecast to represent 39.4% in 2026, attributable to clinician-led selection and medical-use controls.

Hospital teams check glucose management, renal condition, swallowing ability, appetite and overall food intake before recommending enteral nutrition or oral supplements. This makes hospital pharmacy one of the important channels for first product selection, especially where protein level and serving concentration cannot be decided only with age. The 2026 ESPEN guideline library continues to place medical nutrition within defined clinical-use boundaries. Hospital pharmacy can also connect product recommendation with medicines and the existing nutrition plan. After product suitability is established, later packs can be purchased through retail pharmacy, online and home delivery. Hence, hospital pharmacy demand is expected to remain higher at clinical initiation, while regular repeat purchase can move towards home channels.

  • Hospital pharmacy is forecast at 39.4% in 2026 owing to clinician-led product selection.
  • Later refills can move to retail or home delivery without changing the established formula.

What are the drivers, restraints, and opportunities in the Diabetic Sarcopenia Nutrition Market?

In the diabetic sarcopenia nutrition market, the key driver is combined muscle and glucose care, the key restraint is clinical heterogeneity, and the key opportunity is compact targeted nutrition.

  • Driver: Older-adult diabetes care increasingly assesses frailty, muscle strength, and nutrition beside glucose management.
  • Restraint: Renal function, swallowing ability, appetite, medications, and reimbursement can narrow appropriate use.
  • Opportunity: Low-volume RTD and HMB or leucine-enriched formulas can support measured nutrition in homecare.

Frailty Screening Changes Nutrition Decisions

Increasing screening for frailty, weakness and poor intake is changing nutrition decisions in older-adult diabetes care. The 2026 ADA standards recommend annual screening for frailty and other geriatric syndromes among older adults with diabetes. Demand for targeted protein enrichment is expanding as clinicians evaluate transitions between oral intake and parenteral nutrition across acute care pathways. This screening identifies nutrition gap which can remain missed when the treatment is mainly focused on blood glucose. Once poor intake or loss of strength is identified, measured protein nutrition can be added in the existing meal and medicine routine. Therefore, screening is expected to increase number of patients considered for specialized nutrition. However, documented requirement will only start product use, whereas tolerance, affordability and regular availability will decide the repeat demand.

Clinical Differences Limit Standard Protocols

Older adults with diabetes vary in renal function, swallowing ability, appetite, cognition and number of medicines, due to which high-protein formulations cannot simply replicate generic protein powder recipes. In March 2026, KDIGO guidelines highlighted that dietary protein intake must be calibrated against glomerular filtration rate in diabetic kidney disease. These conditions can change protein quantity, product texture, serving volume and caregiver support required for daily use. Clinical differences are therefore expected to restrict standard ordering and increase professional assessment. Products having only diabetes positioning without suitable kidney, swallowing or appetite fit can possibly witness lower adoption.

Targeted Ingredients Create Trial Routes

Increasing research around HMB, leucine and concentrated whey protein ingredients is creating growth prospects for targeted muscle-support formulas. Japan registered the DIAMOND-RCT in August 2026 for studying HMB-Ca among adults aged 65 years or older with type 2 diabetes, using physical function and skeletal muscle outcomes. This trial does not establish product efficacy; however, it shows that diabetes and muscle-focused ingredients are being assessed together. This research direction can lead to development of HMB or leucine-enriched diabetic blends in compact servings. In addition, targeted ingredients can help companies in differentiating these products from general diabetes nutrition. Evidence regarding dose, tolerance, glucose fit and regular use will however be required before wider clinical adoption.

Which country CAGRs are profiled in the Diabetic Sarcopenia Nutrition Market?

Diabetic Sarcopenia Nutrition Market Growth by Market map showing country CAGRs: Japan 10.2%, South Korea 9.9%, USA 9.2%, UK 8.9%, Germany 8.3%
Diabetic Sarcopenia Nutrition Market Growth by Market
Country CAGR
Japan 10.2%
South Korea 9.9%
USA 9.2%
UK 8.9%
Germany 8.3%

How do country-level CAGRs compare in the diabetic sarcopenia nutrition market?

Country demand is expected to remain higher where diabetes care already checks poor intake, muscle function and frailty. Wider hospital, pharmacy and homecare routes can continue the same product after discharge, which supports regular sales. However, reimbursement, prescription rules and medical-necessity documentation can possibly add one more step before product adoption.

  • Japan links diabetes management with sarcopenia research and an established older population.
  • South Korea has rising older-adult diabetes case volume and a national focus on individualized management.
  • USA demand benefits from a large older diabetes population and broad pharmacy-to-home access.
  • UK demand follows screening and structured support before oral supplements are continued.
  • Germany keeps medical-necessity and clinical-use boundaries central to specialized nutrition.

Full report country CAGRs cover: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.

Country-wise Analysis

  • Japan diabetic sarcopenia nutrition demand is projected to rise at 10.2% CAGR during the forecast period. The country has a large older population and increasing clinical attention towards diabetes and muscle loss together. A 2026 Japanese study from the Bunkyo Health Study identified diabetes as a significant sarcopenia risk factor in both sexes, linking elevated blood glucose with reduced muscle mass. Such developments are expected to increase demand for compact formulas providing measured protein and controlled carbohydrate delivery. However, evidence for physical function, renal suitability and professional qualification is expected to remain important for higher adoption.
  • Diabetic sarcopenia nutrition demand in South Korea is forecast to expand at 9.9% CAGR through 2036. A 2025 Korean Diabetes Association review reported that the absolute number of newly diagnosed diabetes cases among older adults doubled over the previous decade. The review also reported rising comorbidities and need for individualized management. Increasing diabetes burden with chronic kidney disease, dementia and different living arrangements is expected to generate demand for nutrition having suitable protein level, texture and serving volume. Hospital initiation followed by pharmacy or home replenishment can be the clearer sales route in the country. However, one common formula cannot serve the complete older-adult population, due to which assessment and caregiver guidance is expected to remain important for regular use.
  • Sales of diabetic sarcopenia nutrition in the USA are forecast to increase at 9.2% CAGR through 2036. In March 2026, the Centers for Disease Control and Prevention reported that diabetes prevalence reached 28.8% among US adults aged 65 years or older. This large patient base and early screening can identify poor intake and reduction in function before an acute hospital event. The USA has hospital pharmacy, retail pharmacy, online and homecare channels, due to which the same product can continue after clinical initiation. As a result, demand is expected to remain higher where medical teams connect protein and calorie intake with glucose management. Household cost and coverage will still decide regular purchase of premium formulas.
  • The diabetic sarcopenia nutrition market in the UK is anticipated to grow at 8.9% CAGR between 2026 and 2036. The March 2025 government diabetes profile reported that 98.2% of GP practices in England participated in the National Diabetes Audit for the reported period. This wider diabetes-care route can identify frailty, poor intake and functional decline among older adults. Compact servings are expected to support product use where poor appetite restricts a larger drink. However, oral nutrition will depend on documented risk, safe swallowing and suitability of protein intake. Consistent guidance across hospital, community and pharmacy settings is expected to support product continuation, whereas qualification can possibly restrict unnecessary use.
  • Germany is estimated to record 8.3% CAGR over the forecast period, owing to formal clinical nutrition use and an aging chronic-care population. Robert Koch Institute researchers reported in September 2025 that diagnosed type 2 diabetes affected 6.05 million people in Germany. Therefore, a specialized formula needs to serve defined nutrition requirement and cannot depend only on general healthy-aging positioning. Products having compact volume, clear clinical positioning and availability from professional recommendation to home use are expected to witness higher demand in the country.

Who are the notable companies in the Diabetic Sarcopenia Nutrition Market?

Abbott, Nestlé Health Science, Danone Nutricia, Meiji, Ajinomoto, Fresenius Kabi, Morinaga Milk Industry, and Medtrition are notable companies profiled in this market.

Diabetic Sarcopenia Nutrition Market Company Highlight
Diabetic Sarcopenia Nutrition Market Company Highlight

The diabetic sarcopenia nutrition market has large medical-nutrition companies along with specialists offering amino acids and concentrated protein. Abbott, Nestlé Health Science, Danone Nutricia and Fresenius Kabi have wider hospital and home-use channels, due to which these companies can support the product from clinical recommendation to household purchase. Meiji and Ajinomoto have metabolic nutrition and amino-acid formulation experience. Morinaga Milk Industry and Medtrition participate through older-adult research and compact protein delivery. Increasing demand is expected to make companies focus on carbohydrate design, protein quality, serving volume, swallowing suitability and product availability after discharge. However, public evidence does not confirm one revenue-share leader in this defined category.

  • Disease-specific ONS platforms: Abbott, Nestlé Health Science, Danone Nutricia, and Fresenius Kabi.
  • Amino-acid and metabolic nutrition specialists: Meiji and Ajinomoto.
  • Clinical protein and older-adult nutrition specialists: Morinaga Milk Industry and Medtrition.

Competitive Benchmarking: Diabetic Sarcopenia Nutrition Market

Company Glycemic formulation Muscle-focused protein Home continuity Reach
Abbott High High High High
Nestlé Health Science High Medium High High
Danone Nutricia Medium Medium High High
Meiji High Medium Medium Medium
Ajinomoto Low High Medium High
Fresenius Kabi High High High High
Morinaga Milk Industry Low Medium Medium Medium
Medtrition Low High High Medium

Key Developments in the Diabetic Sarcopenia Nutrition Market

  • In November 2025, Abbott launched a reformulated Ensure Diabetes Care with low-GI carbohydrates, high protein, and high fiber. The company linked the product with lean-muscle preservation during weight loss.
  • In July 2025, Danone completed its majority acquisition of Kate Farms. Danone said the combined North American medical-nutrition business would reach hospitals, homes, online channels, and retail.

Key Players in the Diabetic Sarcopenia Nutrition Market

Disease-Specific ONS Platforms

  • Abbott
  • Nestlé Health Science
  • Danone Nutricia
  • Fresenius Kabi

Amino-Acid and Metabolic Nutrition Specialists

  • Meiji
  • Ajinomoto

Clinical Protein and Older-Adult Nutrition Specialists

  • Morinaga Milk Industry
  • Medtrition

Diabetic Sarcopenia Nutrition Market - Report Scope

Coverage field Report scope
Market breakdown Formulation; product form; age group; end user; sales channel
Quantitative units USD million
Market definition Revenue from specialized oral and medical nutrition products for older adults with diabetes and sarcopenia, frailty, or muscle-loss risk. Diabetes drugs, general foods, sports nutrition, and exercise services are excluded.
Regions covered North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa
Countries profiled Japan; South Korea; USA; UK; Germany; additional countries in the full report
Key companies Abbott; Nestlé Health Science; Danone Nutricia; Meiji; Ajinomoto; Fresenius Kabi; Morinaga Milk Industry; Medtrition
Forecast period 2026 to 2036
Approach The Future Market Insights report covers product revenue, clinical-use conditions, channel access, segment structure, and country demand.

Diabetic Sarcopenia Nutrition Market - Research Methodology

Method Approach
Primary Research FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Diabetic Sarcopenia Nutrition Market by Segments

Diabetic Sarcopenia Nutrition Market by Formulation

  • Low-GI high-protein ONS
  • Leucine or HMB-enriched diabetic blends
  • Whey-based diabetic protein powders
  • Others

Diabetic Sarcopenia Nutrition Market by Product form

  • RTD
  • Powders
  • Puddings and semi-solids
  • Others

Diabetic Sarcopenia Nutrition Market by Age group

  • 60-69 years
  • 70-79 years
  • 80+ years

Diabetic Sarcopenia Nutrition Market by End user

  • Homecare
  • Long-term care
  • Hospitals
  • Others

Diabetic Sarcopenia Nutrition Market by Sales channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online
  • Institutional tender
  • Others

Diabetic Sarcopenia Nutrition Market by Region

  • North America
    • United States
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
  • Western Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Benelux
    • Nordics
  • Eastern Europe
    • Poland
    • Czech Republic
    • Romania
    • Hungary
  • East Asia
    • Japan
    • South Korea
  • South Asia and Pacific
    • ASEAN
    • Australia and New Zealand
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Türkiye
    • Israel

Research Sources and Bibliography

This bibliography is provided for reader reference. The full report contains the complete reference list and detailed citations.

This Report Answers

  • What is the Diabetic Sarcopenia Nutrition Market worth in 2026?
  • What value is the Diabetic Sarcopenia Nutrition Market projected by 2036?
  • Which formulation holds notable Diabetic Sarcopenia Nutrition Market share?
  • Which product form holds notable Diabetic Sarcopenia Nutrition Market share?
  • Which countries have notable Diabetic Sarcopenia Nutrition Market growth?
  • Which companies are notable in Diabetic Sarcopenia Nutrition Market today?

Table of Content

  1. Key Takeaways
    • Market Size and CAGR
    • Top Growth Driver
    • Fastest Growing Segment
    • Leading Region
    • Key Companies
    • Emerging Opportunities
  2. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
    • Analyst Perspective (What is happening? Why now? What should investors know?)
    • Key Questions Answered
      • How large is the market?
      • What is the CAGR?
      • What are key trends?
      • Which region dominates?
      • Who are the leaders?
Read More...
  1. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  2. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
      • Expert Input and Fieldwork (Primary Evidence)
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
    • Quality Assurance and Audit Trail
  3. Market Background
    • Market Dynamics (Drivers, Restraints, Opportunity, Trends)
    • Scenario Forecast (Optimistic, Likely, Conservative)
    • Impact Analysis
      • AI Impact
      • Sustainability Impact
      • Regulatory Impact
      • Technology Impact
    • Consumer / Buyer Analysis
      • Purchase Drivers
      • Adoption Barriers
      • Buyer Journey
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter's Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. Global Market Analysis and Forecast, 2021 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. Global Market Pricing Analysis, 2021 to 2036
  6. Global Market Analysis and Forecast, By Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Diabetic Sarcopenia Nutrition Market by Formulation, 2026 to 2036
      • Low-GI high-protein ONS
      • Leucine or HMB-enriched diabetic blends
      • Whey-based diabetic protein powders
      • Others
    • Y-o-Y Growth Trend Analysis By Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2025
    • Absolute $ Opportunity Analysis By Diabetic Sarcopenia Nutrition Market by Formulation, 2026 to 2036
  7. Global Market Analysis and Forecast, By Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Diabetic Sarcopenia Nutrition Market by Product form, 2026 to 2036
      • RTD
      • Powders
      • Puddings and semi-solids
      • Others
    • Y-o-Y Growth Trend Analysis By Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2025
    • Absolute $ Opportunity Analysis By Diabetic Sarcopenia Nutrition Market by Product form, 2026 to 2036
  8. Global Market Analysis and Forecast, By Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Diabetic Sarcopenia Nutrition Market by Age group, 2026 to 2036
      • 60-69 years
      • 70-79 years
      • 80+ years
    • Y-o-Y Growth Trend Analysis By Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2025
    • Absolute $ Opportunity Analysis By Diabetic Sarcopenia Nutrition Market by Age group, 2026 to 2036
  9. Global Market Analysis and Forecast, By Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Diabetic Sarcopenia Nutrition Market by End user, 2026 to 2036
      • Homecare
      • Long-term care
      • Hospitals
      • Others
    • Y-o-Y Growth Trend Analysis By Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2025
    • Absolute $ Opportunity Analysis By Diabetic Sarcopenia Nutrition Market by End user, 2026 to 2036
  10. Global Market Analysis and Forecast, By Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 to 2036
      • Hospital pharmacy
      • Retail pharmacy
      • Online
      • Institutional tender
      • Others
    • Y-o-Y Growth Trend Analysis By Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2025
    • Absolute $ Opportunity Analysis By Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 to 2036
  11. Global Market Analysis and Forecast, By Region, 2021 to 2036
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
      • Eastern Europe
      • East Asia
      • South Asia and Pacific
      • Middle East and Africa
    • Market Attractiveness Analysis By Region
  12. North America Market Analysis and Forecast, By Country, 2021 to 2036
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • United States
        • Canada
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  13. Latin America Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Chile
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  14. Western Europe Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • France
        • United Kingdom
        • Italy
        • Spain
        • Benelux
        • Nordics
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  15. Eastern Europe Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Poland
        • Czech Republic
        • Romania
        • Hungary
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  16. East Asia Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Japan
        • South Korea
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  17. South Asia and Pacific Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • ASEAN
        • Australia and New Zealand
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  18. Middle East and Africa Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • GCC Countries
        • South Africa
        • Türkiye
        • Israel
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Market Attractiveness Analysis
      • By Country
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Key Takeaways
  19. Key Countries Market Analysis
    • United States
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Chile
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • United Kingdom
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Italy
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • ASEAN
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Australia and New Zealand
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Japan
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • South Korea
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Poland
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Hungary
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • Türkiye
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
    • South Africa
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Diabetic Sarcopenia Nutrition Market by Formulation
        • By Diabetic Sarcopenia Nutrition Market by Product form
        • By Diabetic Sarcopenia Nutrition Market by Age group
        • By Diabetic Sarcopenia Nutrition Market by End user
        • By Diabetic Sarcopenia Nutrition Market by Sales channel
  20. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Diabetic Sarcopenia Nutrition Market by Formulation
      • By Diabetic Sarcopenia Nutrition Market by Product form
      • By Diabetic Sarcopenia Nutrition Market by Age group
      • By Diabetic Sarcopenia Nutrition Market by End user
      • By Diabetic Sarcopenia Nutrition Market by Sales channel
      • Emerging Startups
      • Innovation Benchmarking
    • Competition Analysis
      • Competition Deep Dive
        • Abbott
          • Overview
          • Product Portfolio
          • Profitability by Market Segments
          • Sales Footprint
          • Strategy Overview
            • Marketing Strategy
            • Product Strategy
            • Channel Strategy
        • Nestlé Health Science
        • Danone Nutricia
        • Meiji
        • Ajinomoto
        • Fresenius Kabi
        • Morinaga Milk Industry
        • Medtrition
      • Case Studies
      • Success Stories
      • Recent Developments
  21. Assumptions & Acronyms Used

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 5: Global Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 6: Global Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 7: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 9: North America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 10: North America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 11: North America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 12: North America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 13: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 14: Latin America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 15: Latin America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 16: Latin America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 17: Latin America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 18: Latin America Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 19: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 20: Western Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 21: Western Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 22: Western Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 23: Western Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 24: Western Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 25: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 26: Eastern Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 27: Eastern Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 28: Eastern Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 29: Eastern Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 30: Eastern Europe Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 31: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 32: East Asia Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 33: East Asia Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 34: East Asia Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 35: East Asia Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 36: East Asia Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 37: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 38: South Asia and Pacific Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 39: South Asia and Pacific Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 40: South Asia and Pacific Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 41: South Asia and Pacific Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 42: South Asia and Pacific Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036
  • Table 43: Middle East and Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 44: Middle East and Africa Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Formulation, 2021 to 2036
  • Table 45: Middle East and Africa Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Product form, 2021 to 2036
  • Table 46: Middle East and Africa Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Age group, 2021 to 2036
  • Table 47: Middle East and Africa Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by End user, 2021 to 2036
  • Table 48: Middle East and Africa Market Value (USD Million) Forecast by Diabetic Sarcopenia Nutrition Market by Sales channel, 2021 to 2036

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021-2036
  • Figure 3: Global Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 5: Global Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 6: Global Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 8: Global Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 9: Global Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 11: Global Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 12: Global Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 14: Global Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 15: Global Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 16: Global Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 17: Global Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 18: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 19: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
  • Figure 20: Global Market Attractiveness Analysis by Region
  • Figure 21: North America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 22: Latin America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 23: Western Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 24: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 25: East Asia Market Incremental Dollar Opportunity, 2026-2036
  • Figure 26: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
  • Figure 27: Middle East and Africa Market Incremental Dollar Opportunity, 2026-2036
  • Figure 28: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 29: North America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 30: North America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 31: North America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 32: North America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 33: North America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 34: North America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 35: North America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 36: North America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 37: North America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 38: North America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 39: North America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 40: North America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 41: North America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 42: North America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 43: North America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 44: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 45: Latin America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 46: Latin America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 47: Latin America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 48: Latin America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 49: Latin America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 50: Latin America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 51: Latin America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 52: Latin America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 53: Latin America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 54: Latin America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 55: Latin America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 56: Latin America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 57: Latin America Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 58: Latin America Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 59: Latin America Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 60: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 61: Western Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 62: Western Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 63: Western Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 64: Western Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 65: Western Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 66: Western Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 67: Western Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 68: Western Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 69: Western Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 70: Western Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 71: Western Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 72: Western Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 73: Western Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 74: Western Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 75: Western Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 76: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 77: Eastern Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 78: Eastern Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 79: Eastern Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 80: Eastern Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 81: Eastern Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 82: Eastern Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 83: Eastern Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 84: Eastern Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 85: Eastern Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 86: Eastern Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 87: Eastern Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 88: Eastern Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 89: Eastern Europe Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 90: Eastern Europe Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 91: Eastern Europe Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 92: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 93: East Asia Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 94: East Asia Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 95: East Asia Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 96: East Asia Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 97: East Asia Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 98: East Asia Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 99: East Asia Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 100: East Asia Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 101: East Asia Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 102: East Asia Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 103: East Asia Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 104: East Asia Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 105: East Asia Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 106: East Asia Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 107: East Asia Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 108: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 109: South Asia and Pacific Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 110: South Asia and Pacific Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 111: South Asia and Pacific Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 112: South Asia and Pacific Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 113: South Asia and Pacific Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 114: South Asia and Pacific Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 115: South Asia and Pacific Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 116: South Asia and Pacific Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 117: South Asia and Pacific Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 118: South Asia and Pacific Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 119: South Asia and Pacific Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 120: South Asia and Pacific Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 121: South Asia and Pacific Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 122: South Asia and Pacific Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 123: South Asia and Pacific Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 124: Middle East and Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 125: Middle East and Africa Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Formulation, 2026 and 2036
  • Figure 126: Middle East and Africa Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Formulation, 2026-2036
  • Figure 127: Middle East and Africa Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Formulation
  • Figure 128: Middle East and Africa Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Product form, 2026 and 2036
  • Figure 129: Middle East and Africa Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Product form, 2026-2036
  • Figure 130: Middle East and Africa Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Product form
  • Figure 131: Middle East and Africa Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Age group, 2026 and 2036
  • Figure 132: Middle East and Africa Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Age group, 2026-2036
  • Figure 133: Middle East and Africa Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Age group
  • Figure 134: Middle East and Africa Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by End user, 2026 and 2036
  • Figure 135: Middle East and Africa Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by End user, 2026-2036
  • Figure 136: Middle East and Africa Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by End user
  • Figure 137: Middle East and Africa Market Value Share and BPS Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026 and 2036
  • Figure 138: Middle East and Africa Market Y-o-Y Growth Comparison by Diabetic Sarcopenia Nutrition Market by Sales channel, 2026-2036
  • Figure 139: Middle East and Africa Market Attractiveness Analysis by Diabetic Sarcopenia Nutrition Market by Sales channel
  • Figure 140: Global Market - Tier Structure Analysis
  • Figure 141: Global Market - Company Share Analysis

Frequently Asked Questions

How large is the Diabetic Sarcopenia Nutrition Market in 2026?

Future Market Insights estimates that the diabetic sarcopenia nutrition market will reach USD 263.4 million in 2026, up from USD 240.3 million in 2025. The market is projected to expand further and reach USD 658.7 million by 2036.

What CAGR is projected for this market through 2036?

As per FMI, the diabetic sarcopenia nutrition market is projected to grow at a 9.6% CAGR from 2026 to 2036. Growth is supported by increasing frailty screening and longer nutrition use at home.

Which formulation holds a notable share during 2026?

Future Market Insights projects low-GI high-protein ONS to hold 41.6% of formulation demand in 2026. Protein delivery with controlled carbohydrate intake supports the segment preference.

Which product form holds a notable share during 2026?

FMI finds that RTD will hold 46.3% of product form demand in 2026. Demand is supported by measured servings, compact volume, and no mixing requirement.

Which country has a notable market expansion outlook?

Future Market Insights predicts Japan to expand at a 10.2% CAGR during the 2026 to 2036 assessment period. Growth is supported by increasing clinical attention towards diabetes and muscle loss together.

Which companies are notable in this market today?

As per FMI analysis, notable companies include Abbott, Nestlé Health Science, Danone Nutricia, Meiji, Ajinomoto, Fresenius Kabi, Morinaga Milk Industry, and Medtrition. These companies are focusing on formulation design, compact servings, and clinical evidence.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.

Future Market Insights

Diabetic Sarcopenia Nutrition Market